210 related articles for article (PubMed ID: 11039177)
1. [IgD myeloma manifesting as acute renal insufficiency].
Duvic C; Sarret D; De Revel T; Hérody M; Didelot F; Labaye J; Nédélec G
Rev Med Interne; 2000 Sep; 21(9):799-803. PubMed ID: 11039177
[TBL] [Abstract][Full Text] [Related]
2. Kidney failure as an unusual initial presentation of biclonal gammopathy (IgD multiple myeloma associated with light chain disease)--a case report.
Rabrenović V; Mijušković Z; Marjanović S; Rabrenović M; Jovanović D; Antić S; Ignjatović L; Petrović M; Pilcević D
Vojnosanit Pregl; 2015 Feb; 72(2):196-9. PubMed ID: 25831916
[TBL] [Abstract][Full Text] [Related]
3. IgD multiple myeloma with renal involvement: case report.
Homan H; Ohtubo Y; Ito H; Azuma K; Yasumoto Y; Ohtuka H; Uomizu K; Yamashita W; Uemura S; Ohsaki K
Jpn J Med; 1990; 29(2):212-5. PubMed ID: 2232370
[TBL] [Abstract][Full Text] [Related]
4. Multiple myeloma--presenting as acute kidney injury.
Prakash J; Niwas SS; Parekh A; Vohra R; Wani IA; Sharma N; Usha
J Assoc Physicians India; 2009 Jan; 57():23-6. PubMed ID: 19753754
[TBL] [Abstract][Full Text] [Related]
5. Myeloma with two monoclonal IgG and IgD in serum: a case report.
Franck P; Petitpain N; Guerci AP; Denisart S; Jacob C; Guéant JL
Acta Haematol; 1994; 92(3):144-7. PubMed ID: 7871954
[TBL] [Abstract][Full Text] [Related]
6. [An elderly patient with IgD myeloma associated with renal amyloidosis and acute renal failure].
Kiyatake I; Tomino Y; Funabiki K; Kubokawa Y; Shirato I; Kubota M; Koide H
Nihon Jinzo Gakkai Shi; 1989 Jul; 31(7):791-6. PubMed ID: 2511365
[TBL] [Abstract][Full Text] [Related]
7. [IgD-lambda type multiple myeloma associated with IgG-kappa type benign monoclonal gammopathy].
Shimada H; Nishinarita S; Kishigami Y; Hayama T; Sawada U; Horie T; Nakamura N; Kato M; Hirano M; Nakamura O
Nihon Rinsho Meneki Gakkai Kaishi; 1995 Apr; 18(2):235-40. PubMed ID: 7553059
[TBL] [Abstract][Full Text] [Related]
8. IgD multiple myeloma: Clinical, biological features and prognostic value of the serum free light chain assay.
Djidjik R; Lounici Y; Chergeulaïne K; Berkouk Y; Mouhoub S; Chaib S; Belhani M; Ghaffor M
Pathol Biol (Paris); 2015 Sep; 63(4-5):210-4. PubMed ID: 26294067
[TBL] [Abstract][Full Text] [Related]
9. [Multiple myeloma of the IgD-lambda type invading CNS].
Kitamura K; Takeuchi J; Kanbe E; Oka H; Saiki M; Aikawa S; Kura Y; Hatta Y; Yamazaki T; Ito T; Sawada U; Horie T
Rinsho Ketsueki; 2004 Oct; 45(10):1124-8. PubMed ID: 15553049
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of immunoglobulin D myeloma by bortezomib and dexamethasone therapy.
Sekiguchi N; Takezako N; Nagata A; Wagatsuma M; Noto S; Yamada K; Miwa A
Intern Med; 2011; 50(21):2653-7. PubMed ID: 22041375
[TBL] [Abstract][Full Text] [Related]
11. IgD kappa myeloma: a new case.
Amine B; Benbouazza K; Harzy T; Rahmouni R; Guedira N; Lazrak N; Hajjaj-Hassouni N
Joint Bone Spine; 2004 Jul; 71(4):331-3. PubMed ID: 15288860
[TBL] [Abstract][Full Text] [Related]
12. [Withdrawal of maintenance dialysis in a patient with diagnosed multiple myeloma and renal failure as a consequence of effective anti-tumor treatment].
Rosa J; Sydor A; Jurczyszyn A; Zabawa-Hołyś S; Nowak J; Czapkowicz-Gryszkiewicz L; Sułowicz W
Przegl Lek; 2010; 67(7):547-50. PubMed ID: 21387773
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin D myeloma--problems with diagnosing and staging (own experience and literature review).
Kuliszkiewicz-Janus M; Zimny A; Sokolska V; Saşiadek M; Kuliczkowski K
Leuk Lymphoma; 2005 Jul; 46(7):1029-37. PubMed ID: 16019554
[TBL] [Abstract][Full Text] [Related]
14. Lambda light chain myeloma with oliguric cast nephropathy and remission with bortezomib, doxorubicin and dexamethasone.
Hada R; Poudyal B; Sharma A; Khatri R
JNMA J Nepal Med Assoc; 2012; 52(188):192-5. PubMed ID: 23591252
[TBL] [Abstract][Full Text] [Related]
15. [Systemic amyloidosis associated with IgD-λ multiple myeloma].
Nagamachi Y; Yamauchi N; Muramatsu H; Inomata H; Nozawa E; Koyama R; Ihara K; Nishisato T; Yamada H; Yano T; Kikuchi S; Hirako T; Kitaoka K; Ono K; Ihara H; Kato J
Rinsho Ketsueki; 2011 Dec; 52(12):1888-92. PubMed ID: 22241157
[TBL] [Abstract][Full Text] [Related]
16. [Results of treatment of patients with advanced multiple myeloma with the vincristine-adriamycin-dexamethasone protocol].
Marisavljević D; Bosković D; Radosević N; Elezović I; Tomin D; Gotić M; Antunović P
Srp Arh Celok Lek; 1996; 124(11-12):292-6. PubMed ID: 9132962
[TBL] [Abstract][Full Text] [Related]
17. Satisfactory remission in a case of IgD myeloma: effectiveness of glucocorticoid treatment.
Takemori N; Kondo K; Kawamura T; Imai K; Sakurai H; Sato T
Am J Hematol; 2001 Jan; 66(1):62-3. PubMed ID: 11426497
[TBL] [Abstract][Full Text] [Related]
18. Hemodialysis: an appropriate therapy in myeloma-induced renal failure.
Sharland A; Snowdon L; Joshua DE; Gibson J; Tiller DJ
Am J Kidney Dis; 1997 Dec; 30(6):786-92. PubMed ID: 9398122
[TBL] [Abstract][Full Text] [Related]
19. [Improved prognosis of generalized AL-amyloidosis in a patient with multiple myeloma treated according to the VAD protocol].
Sarkisova IA; Rameev VV; Kozlovskaia LV; Andreeva NE
Ter Arkh; 2003; 75(8):81-2. PubMed ID: 14520860
[No Abstract] [Full Text] [Related]
20. Unusual myelomas: a review of IgD and IgE variants.
Pandey S; Kyle RA
Oncology (Williston Park); 2013 Aug; 27(8):798-803. PubMed ID: 24133829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]